The eye is the window to patient health.
Optain’s non-invasive clinical support tools harness the power of AI-enabled algorithms to analyse full-colour retinal images to screen for referable diseases and evaluate patient’s health.
We look into the future and see a better quality of life.
Our future health depends on early detection of disease. Artificial intelligence and deep learning algorithms can analyse enormous data sets far beyond human capabilities with unrivalled accuracy. We see a world where early detection of chronic disease through AI-enabled health assessments is universally accessible to all.
Non-Invasive, Real-Time, Proven.
Providers take retinal images using the Optain camera.
Optain’s AI algorithms immediately analyze images.
Optain generates a risk assessment report on various health conditions.
Founded by the world’s leading expert in ophthalmology AI.
We are led by a team of clinicians, scientists, engineers, and business leaders driven to advance healthcare access, quality, and outcomes across the world.
Elevating health
Optain improves the speed to diagnosis, democratizes access to specialized disease screening, reduces the risk of missed diagnoses and identifies cases that may require further investigation.
For Providers
Create an accurate assessment of patient health to minimize missed diagnoses and standardize care recommendations.
For Patients
Receive extensive, AI-enabled, accurate reports to better understand your eye and whole-body health.
For Insurers
Screen, risk stratify, and detect eye and chronic diseases in member populations.
For Pharmaceutical Companies
Leverage nearly 140 unique condition markers to inform drug development and trial formation.
Testimonials
“It gives me more information, and therefore confidence, when discussing a patient’s eye health.”
“It’s sensational, so easy to use with instantaneous results. We have used it on most of our patients, we are a high pathology clinic and it is great to have this added support.”
“It is a great clinical tool that aids in quality discussions with patients.”
“It’s that extra bit of assurance…it just gives me that extra reassurance on those borderline cases.”
Partners & Affiliates
Backed by the world’s leading researchers, clinicians, and industry partners.
